Sage Journals: Discover world-class research

Abstract

The objectives of this study are to measure the level of income of primary health care institutions during essential medicines system (EMS) implementation and to identify its main influencing factors for finding the evidence to promote the EMS in China’s deepening health care reform.

The field investigation with a stratified sampling method contained primary health institutions from Hubei province, based on the different economic levels. Government-run institutions which implemented EMS were all collected; they were a total of 402. A structured questionnaire survey was carried out at all institutions involving indicators such as income of primary health care institutions, government subsidy, institution staff salaries, institution indebtedness, number of health personnel, drug price cut (per cent) and number of drug use. The Statistical Package for the Social Sciences (SPSS) 12.0 was used for independent variables selection and to perform multiple linear regressions.

Government subsidy (X₁), institution staff salaries (X₂), institution indebtedness (X₃) and number of health personnel (X₄) are factors chosen into the regression model, the square root of the income of primary health institutions (Y). The model Y = 3.827 + 0.030X₁ + 0.045X₂ + 0.002X₃ + 0.033X₄ (F = 164.663, P < 0.001), where coefficient of determination R² = 0.656. The biggest influence on income of primary health institutions is institution staff salaries (standardized coefficients = 0.398), followed by number of health personnel (standardized coefficients = 0.318) and government subsidy (standardized coefficients = 0.264).

To protect the income of primary health care institutions, more attention should be paid to the agency staffing reform, individual performance appraisal and government subsidies. For best outcomes of EMS, the subsequent implementation should be a more completed set of supporting measures besides the design of system itself.

Keywords

Essential medicines influence factors government subsidy staff salaries health personnel primary health care institutions China

Get full access to this article

View all access options for this article.

References

Alejos

Weingartner

Scharff

D.P.

Ablah

Frazier

Hawley

S.R.

Romain

T.S.

Orr

S.A.

Wright

K.S.

(2008). Ensuring the success of local public health workforce assessments: Using a participatory-based research approach with a rural population. Public Health, 122(12), 1447–55.

Benjamin

Schlessor

Marita

(2001). Assessing community health among indigenous populations in Ecuador with a participatory approach: Implications for health reform. Journal of Community Health, 26(2), 133–47.

Chen

Tang

Sun

Ross-Degnan

Wagner

A.K.

(2010). Availability and use of essential medicines in China: Manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Service Reseach, 10(211). Retrieved from http://www.biomedcentral.com/1472-6963/10/211.

China National Health Economics Institute (2008). China national health accounts report. Beijing: China National Health Economics Institute.

D’Souza

Lalitha

(2000). Community health workers: A way forward. Journal of Management in Medicine, 14(1), 77–80.

Eggleston

Meng

Lindelow

Wagstaff

(2008). Health service delivery in China: A literature review. Health Economics, 17(2), 149–65.

Fang

W.J.

T.T.

Guo

M.Y.

W.Q.

(2010). Investigation and evaluation of the application of essential drug in Songjiang district medical institutions of Shanghai. China Pharmacy, 21(20), 1910–12.

Gao

G.Y.

Han

Y.L.

Zhu

Z.F.

Cui

Wang

L.S.

(2009). Study on the effective of the drugs zero-profit in Beijing township health centre. Chinese Hospitals, 13(7), 21–25.

Hao

Hassan

H.D.

Minmin

Gang

Xinping

(2010). Prices, availability and affordability of essential medicines in rural areas of Hubei province, China. Health Policy Plan, 25(3), 219–29.

10.

Hou

Z.Y.

Meng

Q.Y.

Zhao

M.M.

(2010). Research on the current situation of public financing of primary health care providers in China. Chinese Health Economics, 29(4), 26–28.

11.

Wang

J.H.

(2010). Analysis of county health human resource in China. Chinese Health Economics, 29, 62–63.

12.

Huish

(2008). Going where no doctor has gone before: The role of Cuba’s Latin American School of Medicine in meeting the needs of some of the world’s most vulnerable populations. Public Health, 122(6), 552–57.

13.

Hyder

Syed

Puvanachandra

Bloom

Sundaram

Mahmood

Iqbal

Hongwen

Ravichandran

Oladepo

Pariyo

Peters

(2010). Stakeholder analysis for health research: Case studies from low- and middle-income countries. Public Health, 124(3), 159–66.

14.

Information Office of the Ministry of Health (2009). Basic health in 2009. Retrieved from http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s3582/201003/46237.htm

15.

Jacobzone

(2004). Pharmaceutical policies in OECD countries: Reconciling social and industrial goals. Paris. Labour Market and Social Policy Occasional Paper No. 40.

16.

Wang

L.G.

Wen

L.Q.

Yin

C.Y.

J.C.

Xiao

L.T.

(2008). On public hospitals ‘make up a double control’ the design of compensation mechanisms. Chinese Journal of Hospital Administration, 24 (1), 661–63.

17.

Liu

F.F.

Y.P.

(2007). An analysis on the policy of declining prices for medicine. Journal of Fujian Medical University (Social Science Edition), 8(4), 1–4.

18.

Liu

G.E.

Tang

(2007). Trend analysis of drug expenditure in China. Chinese Health Economics, 26(12), 5–6. Retrieved from http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohywzc/s3578/200903/39381.htm

19.

Lloyd

(2004). The subsidy of pharmaceuticals in Australia: Processes and challenges. Australian Health Review, 28(2), 194–205.

20.

Malekpour

Mahdi

Fatehizadeh

Mohsen

Hashemian

Seyed Mohammad Reza

Velayati

Ali Akbar

(2009). Retaining health manpower in developing countries. Lancet, 374(9686), 291–92.

21.

Martin

J.C.

Avant

R.F.

Bowman

M.A.

Bucholtz

J.R.

Dickinson

J.R.

Evans

K.L.

Green

L.A.

. (2004). The future of family medicine: A collaborative project of the family medicine community. Annals of Family Medicine, 2(Suppl 1), S3–S32.

22.

Meng

Cheng

Silver

Sun

Rehnberg

Tomson

(2005). The impact of China’s retail drug price control policy on hospital expenditures: A case study in two Shandong hospitals. Health Policy Planning, 20(3), 185–96.

23.

Ministry of Health of the People’s Republic of China (2009a). Accelerate the establishment of national essential drug system.

24.

Ministry of Health of the People’s Republic of China (2009b). Health statistics bulletin 2009, data interpretation. Retrieved from http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/pgb/201006/47784.htm

25.

Ministry of Health of the People’s Republic of China (2009c). National essential medicines list for primary health institutions. Retrieved from http://www.gov.cn/gzdt/2009-08/18/content_1395524.htm

26.

Ministry of Health of the People’s Republic of China (2010). China Health Statistics Yearbook 2010. Retrieved from http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/index2010.html

27.

National Development and Reform Commission (NDRC) (2009). Implementation plan for the recent priorities of the health care system reform (2009–2011). Retrieved from http://shs.ndrc.gov.cn/ygzc/t20090408_359216.html

28.

Neter

John

Michael

H.K.

Christopher

(1996). Applied linear statistical models. McGraw-Hill.

29.

Peng

Y.C.

Chen

Y.J.

Liang

W.N.

(2009). Proposal for a job-analysis based performance appraisal for posts in community healthcare organizations. Chinese Journal of Hospital Administration, 25(2), 110–13.

30.

J.H.

(2010). Consideration of promoting the national essential drug system in the county-level hospitals. China Pharmacist, 13, 872–73.

31.

Schlaff

Anthony L.

(2005). Lack of national primary care organization partnerships with community groups to promote heath care reform. American Journal of Public Health, 95, 832–33.

32.

Seble

Fitzhugh

Perry

W.P.

Heather

(2010). Compulsory service programs for recruiting health workers in remote and rural areas: Do they work? Bulletin of the World Health Organization, 88(5), 364–70.

33.

Tian

Song

Y.R.

Zhang

X.P.

(2010). Analyzing the national system for basic pharmaceuticals with systematology. The Chinese Health Service Management, 262, 243–45.

34.

World Health Organization (2000). MDG 8: Develop a global partnership for development. Retrieved from http://www.who.int/topics/millennium_development_goals/medicines/en/index.html

35.

Yao

Chen

Z.M.

Luo

W.J.

Chen

Q.H.

Shu

(2005). Status of health investment and expenditure effects of their use in China. Chinese Journal of Hospital Administration, 21, 91–94.

36.

Ping

Yang

Wang

K.Y.

Tang

X.C.

(2007). Some foreign countries’ general practitioner training and use of profiles. Journal of Military Surgeon in Southwest, 9, 112–13.

37.

Yip

Eggleston

(2004). Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, China. Social Science & Medicine, 58(2), 267–77.

38.

F.H.

Meng

Q.Y.

Wang

Sun

(2010). Analysis on the measuring method of financing for township health centre within the framework of national essential medicines system: A case in S County. Chinese Journal of Health Policy, 3(10), 29–33.

39.

Zhou

H.S.

Guo

(2007). Analysis on causes and risk of county level hospital developing on liability: Case study on a county hospital. Chinese Hospital Management, 27(12), 37–40.

40.

Zhu

H.P.

(2010). Implementation of essential medicine system in primary healthcare area. China Hospital CEO, 7, 62–64.

Multifactor Analysis on the Income of Primary Health Care Institutions Implementing EMS in Hubei Province,China: A Cross-sectional Study

Abstract

Keywords

Get full access to this article

References